Adding Fat Reducing Drug Does not Help Diabetic Hearts

Wed, 17 Mar 2010
Adding a drug which reduces blood fats called triglycerides to cholesterol -fighting statins gives no additional protection from stroke, heart attack, heart disease and death in patients with Type 2 diabetes .

This is the latest finding from data of a big study.

The study conducted by the National Institute of Health, known as Accord, tried to see if the dual-drug therapy may lower heart disease and stroke-related events in diabetics at especially high risk of serious heart conditions due to other risk factors, like high blood pressure and obesity .

All 5,518 trial participants took Zocor, available generically as simvastatin.

One group also took TriCor, which is designed to reduce blood fats known as triglycerides and increase "good" HDL cholesterol. TriCor is part of a class of drugs called fibrates.

Link to this page

Copy and Paste the following HTML into your page.